Collegium Pharmaceutical (COLL) Deferred Taxes (2021 - 2026)

Collegium Pharmaceutical's Deferred Taxes history runs 6 years deep, the most recent figure standing at -$968000.0 for Q1 2026.

• In Q1 2026, Deferred Taxes fell 79.59% year-over-year to -$968000.0; the TTM figure through Mar 2026 stood at -$26.1 million (down 13.71% YoY), while the FY2025 annual figure was -$25.7 million, up 4.31% from the prior year.
• Deferred Taxes was -$968000.0 for Q1 2026 at Collegium Pharmaceutical, up from -$10.1 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $2.1 million in Q3 2022 to a low of -$12.1 million in Q3 2025.
• Historically, Deferred Taxes has averaged -$3.8 million across 5 years, with a median of -$2.9 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Deferred Taxes surged 656.23% in 2022, then slumped 9491.3% in 2024.
• A 5-year view of Deferred Taxes shows it stood at -$1.1 million in 2022, then surged by 68.65% to -$338000.0 in 2023, then plunged by 2904.73% to -$10.2 million in 2024, then gained by 0.83% to -$10.1 million in 2025, then soared by 90.39% to -$968000.0 in 2026.
• The last three Deferred Taxes figures came in at -$968000.0 (Q1 2026), -$10.1 million (Q4 2025), and -$12.1 million (Q3 2025), per Business Quant data.